;
Skip to main content
Home > Week in Review > Management

Chronological Index of : Management Tracks

 Current Issue
  • Aeterna Zentaris management update

    Aeterna Zentaris Inc. (TSX:AEZ; NASDAQ:AEZS), Quebec City, Quebec Business: Endocrine/Metabolic, Cancer Hired: Philip Theodore as SVP, chief administrative officer, general counsel and corporate secretary, formerly VP, …

    Published on 10/20/2014
  • Allied Minds, Bristol-Myers management update

    Allied Minds plc (LSE:ALM), Boston, Mass. Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Business: Pharmaceuticals Hired: Satish Jindal as CEO of Allied-Bristol Life Sciences LLC, a JV between Allied Minds and …

    Published on 10/20/2014
  • Angiotech management update

    Angiotech Pharmaceuticals Inc., Vancouver, B.C. Business: Autoimmune, Cardiovascular, Dermatology Hired: John Barr as CEO, formerly EVP and president of global surgical at Bausch + Lomb Inc., which Valeant …

    Published on 10/20/2014
  • Atopix Therapeutics board of directors update

    Atopix Therapeutics Ltd., London, U.K. Business: Dermatology Appointed: Deborah Harland, partner at SR One, the VC arm of GlaxoSmithKline plc

    Published on 10/20/2014
  • Catalent management update

    Catalent Inc. (NYSE:CTLT), Somerset, N.J. Business: Supply/Service, Drug delivery Hired: Steven Fasman as SVP and general counsel, formerly EVP of law at MacAndrews & Forbes Holdings Inc.

    Published on 10/20/2014
  • Cognoptix board of directors update

    Cognoptix Inc., Acton, Mass. Business: Diagnostic, Supply/Service Appointed: President and CEO Paul Hartung as chairman

    Published on 10/20/2014
  • Cornerstone Pharmaceuticals management update

    Cornerstone Pharmaceuticals Inc., Cranbury, N.J. Business: Cancer Hired: Steve Carchedi as CEO and a director, formerly president of North America for Mallinckrodt plc; he succeeds Robert Shorr, who remains CSO

    Published on 10/20/2014
  • Coronado Biosciences management update

    Coronado Biosciences Inc. (NASDAQ:CNDO), Burlington, Mass Business: Autoimmune, Cancer Hired: Claude Maraoui as CEO of Coronado's Journey Medical Corp. subsidiary, formerly VP of dermatology sales and executive director…

    Published on 10/20/2014
  • Cortendo management update

    Cortendo AB, Gothenburg, Sweden Business: Endocrine/Metabolic Hired: Robert Lutz as CBO, formerly VP of strategy and new products for the neuroscience business unit at Shire plc

    Published on 10/20/2014
  • Cynapsus management update

    Cynapsus Therapeutics Inc. (TSX-V:CTH; OTCQX:CYNAF), Toronto, Ontario Business: Drug delivery, Neurology Hired: Thierry Bilbault as EVP of chemistry, manufacturing and controls and CSO, formerly technical and industrial…

    Published on 10/20/2014
  • DNAtrix board of directors update

    DNAtrix Inc., Houston, Texas Business: Cancer Appointed: Reenie McCarthy, a director at Morningside Technology Advisory LLC

    Published on 10/20/2014
  • EryDel management update

    EryDel S.p.A., Urbino, Italy Business: Drug delivery, Neurology Hired: Rene Goedkoop as CMO, a newly created position, formerly CMO of Sensimed AG

    Published on 10/20/2014
  • Fibrocell management update

    Fibrocell Science Inc. (NASDAQ:FCSC), Exton, Pa. Business: Gene/Cell therapy Transitioned: Kimberly Smith to interim CFO, treasurer and corporate secretary, while remaining controller; she succeeds Gregory Weaver

    Published on 10/20/2014
  • Folia Biotech management update

    Folia Biotech Inc., Quebec City, Quebec Business: Infectious, Cancer Hired: Louis Lamontagne as CEO; he succeeds Jacques Bernier

    Published on 10/20/2014
  • Kesios management update

    Kesios Therapeutics Ltd., London, U.K. Business: Cancer Hired: Alain Maiore as CEO

    Published on 10/20/2014
  • Merz management update

    Merz GmbH & Co. KGaA, Frankfurt, Germany Business: Pharmaceuticals Transitioned: Patrick Urban to head of Merz's Ulthera Inc. business unit from VP of U.S. sales at Ulthera

    Published on 10/20/2014
  • Myriad Genetics management update

    Myriad Genetics Inc. (NASDAQ:MYGN), Salt Lake City, Utah Business: Diagnostic Hired: R. Bryan Riggsbee as EVP, treasurer and CFO, formerly SVP of corporate finance at Laboratory Corp. of America Holdings; he succeeds …

    Published on 10/20/2014
  • New Haven Pharmaceuticals management update

    New Haven Pharmaceuticals Inc., Guilford, Conn. Business: Cardiovascular, Gastrointestinal Hired: Jeffrey Patrick as CSO, a newly created position, formerly global VP of medical affairs at Mallinckrodt plc; and Michael…

    Published on 10/20/2014
  • Ophthotech management update

    Ophthotech Corp. (NASDAQ:OPHT), New York, N.Y. Business: Ophthalmic Hired: Todd Smith as SVP and chief commercial officer, a newly created position, formerly EVP and chief commercial officer of Horizon Pharma plc

    Published on 10/20/2014
  • Pharmalink board of directors update

    Pharmalink AB, Stockholm, Sweden Business: Renal, Transplant Appointed: Bengt Julander, a director, as chairman; he succeeds Anders Wiklund, who remains a senior advisor

    Published on 10/20/2014
  • Rigontec board of directors update

    Rigontec GmbH, Bonn, Germany Business: Cancer, Infectious Appointed: Regina Hodits, a general partner at Wellington Partners Venture Capital; and Marcus Kostka, a director at Boehringer Ingelheim Venture Fund

    Published on 10/20/2014
  • Sucampo management update

    Sucampo Pharmaceuticals Inc. (NASDAQ:SCMP), Bethesda, Md. Business: Gastrointestinal, Ophthalmic, Neurology Departing: Cary Claiborne as CFO, effective Nov. 7

    Published on 10/20/2014
  • Synlogic management update

    Synlogic Inc., Cambridge, Mass. Business: Gastrointestinal Hired: Paul Miller as CSO, formerly VP of infection biology research at AstraZeneca plc; and Alison Silva as COO, formerly VP of drug development at Marina …

    Published on 10/20/2014
  • Takeda management update

    Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Business: Pharmaceuticals Hired: John Boslego as SVP and head of development for Takeda's global vaccine business unit, effective Dec. 1, formerly director of …

    Published on 10/20/2014
  • TheraVitae management update

    TheraVitae Inc., Toronto, Ontario Business: Gene/Cell therapy Hired: Elmar Burchardt as CEO and a director, effective Oct. 22, formerly VP at Pfizer Inc.; he succeeds Bill Baker, who remains chairman

    Published on 10/20/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993